Margaret Dugan Bei Gene, Ltd. (BGNE) insider trading activity

BGNE Quotes by TradingView

Margaret Dugan is Director of BeiGene, Ltd.. Currently has a direct ownership of 56,940 shares of BGNE, which is worth approximately $12.9 Million. The most recent transaction as insider was on May 21, 2025, when has been sold 10,985 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 56.9K
23.9% 3M change
23.9% 12M change
Total Value Held $12.9 Million

Margaret Dugan Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 21 2025
BUY
Grant, award, or other acquisition
-
10,985 Added 16.17%
56,940 Ordinary Shares
Jun 05 2024
BUY
Grant, award, or other acquisition
-
16,341 Added 26.23%
45,955 Ordinary Shares
Jun 15 2023
BUY
Grant, award, or other acquisition
-
12,922 Added 30.38%
29,614 Ordinary Shares
Jun 22 2022
BUY
Grant, award, or other acquisition
-
16,692 Added 50.0%
16,692 Ordinary Shares

Also insider at

SDGR
Schrodinger, Inc. Healthcare
Chief Medical Officer
MD

Margaret Dugan

Director
Grand Cayman, E9

Track Institutional and Insider Activities on BGNE

Follow BeiGene, Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BGNE shares.

Notify only if

Insider Trading

Get notified when an Bei Gene, Ltd. insider buys or sells BGNE shares.

Notify only if

News

Receive news related to BeiGene, Ltd.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BGNE